Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations-Reference-Cited by-同舟云学术

Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations

Published:2020-03-12 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Hansen Ulla Kring,Ramskov Sofie,Bjerregaard Anne-Mette,Borch Annie,Andersen Rikke,Draghi Arianna,Donia Marco,Bentzen Amalie Kai,Marquard Andrea Marion,Szallasi Zoltan,Eklund Aron Charles,Svane Inge Marie,Hadrup Sine Reker

Funder

H2020 European Research Council

Sundhed og Sygdom, Det Frie Forskningsråd

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Targeting neoantigens to augment antitumour immunity;Yarchoan;Nat Rev Cancer.,2017

2. Neoantigens in cancer immunotherapy;Schumacher;Science.,2015

3. Genetic basis for clinical response to CTLA-4 blockade in melanoma;Snyder;N Engl J Med.,2014

4. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer;Rizvi;Science.,2015

5. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma;Lauss;Nat Commun.,2017

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Phenotype-Genotype Associations in Primary Clear Cell Renal Cell Carcinoma and Matched Metastatic Tissue;Modern Pathology;2024-10

2. A synthetic cytotoxic T cell platform for rapidly prototyping TCR function;npj Precision Oncology;2024-08-19

3. Immunotherapy Applications for Thymine Dimers and WT1 Antigen in Renal Cancers: A Comparative Statistical Analysis;Journal of Personalized Medicine;2024-05-23

4. Tumor Antigens beyond the Human Exome;International Journal of Molecular Sciences;2024-04-25

5. Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies;Human Vaccines & Immunotherapeutics;2024-02-12